Do High-Quality International Stocks Have A Place In Your Portfolio?

Tuesday, July 20, 2021 | Kate Stalter
Do High-Quality International Stocks Have A Place In Your Portfolio?

Nokia (NYSE: NOK), AstraZeneca (NASDAQ: AZN) and ASML Holding (NASDAQ: ASML) are among the most popular non-U.S. developed-market stocks. 

So far in 2021, all three are outperforming the S&P 500, the most widely used benchmark for large-cap domestic stocks. Their gains are: 

  • Nokia: 43.22%
  • AstraZeneca: 15.46%
  • ASML: 41.27%
  • S&P 500: 15.20%

Professional investors understand that balance is crucial in a long-term portfolio. That balance includes several asset classes, including stocks from non-U.S. developed markets. 

In a recent report evaluating prospects for the second half of 2021, brokerage LPL commented on developed international stocks. Analysts wrote, “The improved value-style performance has opened the door for developed international stocks to potentially outperform U.S. stocks for the first time in over a decade. The recovery the U.S. is currently experiencing from COVID-19 still lies ahead for Europe and Japan.”

Wisdom Tree, an exchange-traded fund sponsor and asset manager, also issued a note touting the potential for quality international stocks. By “quality,” Wisdom Tree and others are referring to stocks with growing profitability strong return on equity, return on assets and other measures. Growth investors would add accelerating revenue to that list.

Wisdom Tree uses its International Quality Dividend Growth Fund (BATS: IQDG) as the barometer for international quality. The fund launched in 2016 and has outperformed its benchmark, the MSCI EAFE index over the past year, and has tracked its index closely on a three-year and five-year basis. 

The MSCI EAFE index tracks large- and mid-cap equities across 21 developed market countries, excluding the U.S. and Canada. Since 2018, the S&P 500 outperformed the MSCI EAFE index, but if LPL and Wisdom Tree are correct, that may change.

Wisdom Tree points out that the underperformance since 2018 was due to rallies of lower-quality stocks not tracked in the index. As Wisdom Tree notes, “Lower-quality stocks should trade at a valuation discount to the broader market because they’re assumed to be riskier. Therefore, they should offer more compensation from a total return perspective to entice investors to own them.”

But the situation may be flipping, when it comes to international. Wisdom Tree notes that the “quality factor” means international stocks with strong fundamentals and balance sheets are now available at a value.

Another fund tracking high quality international stocks is the Vanguard International Dividend Appreciation ETF (NASDAQ:VIGI).

The fund focuses on high-quality companies boasting steady dividend growth, likely to appreciate in price over the long haul. 

It currently tracks the Nasdaq International Dividend Achievers Select Index, but plans to switch to the S&P International Dividend Growers Index this quarter.

Both indexes capture the performance of stocks that increased dividends for a minimum of seven years in a row, and eliminate companies likely to slash dividends. 

The top three components within the fund, and their year-to-date returns are:

  • Nestle (OTC: NSRGY): 5.87%
  • Roche Holding (OTC: RHHBY): 12.51%
  • Novartis (NYSE: NVS): -1.83%

In general, the high-quality stocks tracked by this ETF outperform the broader market during downturns, but as three-quarters of stocks follow the broader market’s trend, no equity fund should be treated as a hedge against corrections.

In fact, as U.S. markets plummeted Monday, the MSCI EAFE index fell slightly more. 

Nonetheless, international diversification should be a key component of any investment strategy, but it’s imperative to understand which types of securities belong in your portfolio, and which may not. 

One way to protect your portfolio against downturns is with a focus on dividend payers, which contribute to the total return even amid a price decline. 

The dividend-paying portion of your portfolio may tend to be value-focused, as many growth stocks reinvest profit back into new projects, rather than returning the payout to investors. In the decade between 2000 and 2009, international value, along with several other asset classes, outperformed the S&P 500. Lest you think that’s long in the past and nothing to concern yourself: There’s nothing saying that kind of situation can’t happen again. 

Featured Article: What defines an oversold asset?


7 Stocks That Can Help You Profit From Summer Shortages

One of the lingering impacts of the Covid-19 pandemic is the supply chain disruptions that continue to bedevil many sectors. By now, every investor is aware of the global chip shortage that is disrupting many sectors that were projected to have strong growth in 2021.

But there are many more sectors that are being affected by supply chain disruptions. And this affects everything from big-ticket items like cars to everyday items like pet food and even bacon.

The focus of this special presentation is seven companies that stand to benefit from the current disruption in the supply chain. All of these companies delivered strong gains in 2020. Some of them have weakened in 2021, but that was before the full extent of the supply chain weakness was discovered.

As the economy reopens, the shortage of items is likely to continue and become much more notable. When they do, many of these stocks may get overpriced. That’s why now is the time to get in on these stocks that can help you work the supply chain in your favor.

View the "7 Stocks That Can Help You Profit From Summer Shortages".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Nokia (NOK)1.2$5.84+1.6%N/A-13.58Buy$7.16
ASML (ASML)1.7$754.09+0.8%0.42%55.00Buy$593.00
AstraZeneca (AZN)2.1$56.79-2.5%3.28%37.36Buy$119.00
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.